, Tracking Stock Market Picks
Enter Symbol:
E.i. Du Pont De Nemours And Company (DD) [hlAlert]

Buy DD
up 8.85 %

E.i. Du Pont De Nemours And Company (DD) upgraded to Buy by Citigroup

Posted on: Tuesday,  Sep 22, 2015  10:25 AM ET by Citigroup

Citigroup rated Buy E.i. Du Pont De Nemours And Company (NYSE: DD) on 09/22/2015, when the stock price was $47.79.
Since then, E.i. Du Pont De Nemours And Company has gained 8.85% as of 01/27/2016's recent price of $52.02.
If you would have followed this Citigroup's recommendation on DD, you would have gained 8.85% of your investment in 127 days.

E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.

Citi Investment Research is a highly respected research unit and is comprised of 390 research analysts across 22 countries. Citi Investment Research covers 3,100 companies, representing 90 percent of the market capitalization of the major global indices, and provides macro and quantitative analysis of global markets and sector trends. Combined with Citi's exceptional sales and trading capabilities and Smith Barney's financial consultants, the core focus of the group is to help investing clients make informed decisions by providing value-added, independent, insightful analysis.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/22/2015 10:25 AM Buy
as of 12/24/2008
1 Week up  1.26 %
1 Month up  26.44 %
3 Months up  19.12 %
1 YTD down  -38.20 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/22/2007 9:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy